Advances in molecular genetics and management of hypertrophic cardiomyopathy

JAMA. 1999 May 12;281(18):1746-52. doi: 10.1001/jama.281.18.1746.

Author

L Fananapazir¹

Affiliation

¹ Section of Clinical Electrophysiology and Inherited Cardiac Diseases, Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1650, USA. fananapa@nih.gov

PMID: 10328076
DOI: 10.1001/jama.281.18.1746

No abstract available

Publication types

Case Reports
Clinical Conference

MeSH terms

Adult
Arrhythmias, Cardiac / etiology
Arrhythmias, Cardiac / prevention & control
Cardiomyopathy, Hypertrophic / complications
Cardiomyopathy, Hypertrophic / genetics*
Cardiomyopathy, Hypertrophic / physiopathology
Cardiomyopathy, Hypertrophic / therapy*
Death, Sudden / etiology
Death, Sudden / prevention & control
Disease Progression
Female
Genotype
Humans
Muscle, Skeletal / ultrastructure
Mutation*
Myosins / genetics*
Prognosis
Risk
Sarcomeres / genetics*

Substances

Myosins